{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:43:55Z","timestamp":1777902235019,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["R23087HH"],"award-info":[{"award-number":["R23087HH"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202303016287"],"award-info":[{"award-number":["FRM EQU202303016287"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101095426"],"award-info":[{"award-number":["101095426"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825575"],"award-info":[{"award-number":["825575"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["ANR-23-RHUS-0014"],"award-info":[{"award-number":["ANR-23-RHUS-0014"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847949"],"award-info":[{"award-number":["847949"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE14-0006-01"],"award-info":[{"award-number":["ANR-18-CE14-0006-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhepr.2025.101688","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:03:26Z","timestamp":1764144206000},"page":"101688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elexacaftor\u2013tezacaftor\u2013ivacaftor and cystic fibrosis liver disease: A turning point that calls for cautious optimism"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-1859","authenticated-orcid":false,"given":"Pierre-Emmanuel","family":"Rautou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9164-957X","authenticated-orcid":false,"given":"Sophie","family":"Hillaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6225-2989","authenticated-orcid":false,"given":"Simone","family":"Gambazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-695X","authenticated-orcid":false,"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101688_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/17476348.2024.2365842","article-title":"Management of liver disease and portal hypertension in cystic fibrosis: a review","volume":"18","author":"Colombo","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jhepr.2025.101688_bib2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients","volume":"69","author":"Boelle","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101688_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcf.2021.03.014","article-title":"Ursodeoxycholic acid and liver disease associated with cystic fibrosis: a multicenter cohort study","volume":"21","author":"Colombo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jhepr.2025.101688_bib4","article-title":"Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor","volume":"7","author":"Mouliade","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101688_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2021.09.042","article-title":"Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies","volume":"76","author":"Dana","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101688_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jcf.2019.07.005","article-title":"The role of endothelial cells in cystic fibrosis","volume":"18","author":"Declercq","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jhepr.2025.101688_bib7","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/liv.15748","article-title":"The non-invasive evaluation of liver involvement in patients with cystic fibrosis: a prospective study","volume":"43","author":"Dajti","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101688_bib8","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder","author":"Ciriaci","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101688_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00653-2020","article-title":"Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Le Ribeuz","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhepr.2025.101688_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg8577","article-title":"Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation","volume":"14","author":"Erfinanda","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhepr.2025.101688_bib11","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101688_bib12","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2025.101688_bib13","unstructured":"Zolin A, Adamoli A, Bakkeheim E, et al. ECFSPR annual report 2023. 2025. Available at https:\/\/pr.ecfs.eu\/annual-reports\/"},{"key":"10.1016\/j.jhepr.2025.101688_bib14","unstructured":"Zolin A, McKone E, van Rens J, et al. ECFSPR annual report 2014. 2016. Available at https:\/\/pr.ecfs.eu\/annual-reports\/"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:23:44Z","timestamp":1777634624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2589555925003714"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101688","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor\u2013tezacaftor\u2013ivacaftor and cystic fibrosis liver disease: A turning point that calls for cautious optimism","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101512","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101688"}}